Monroe Capital Corporation (NASDAQ:MRCC - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $7.00 and traded as high as $7.49. Monroe Capital shares last traded at $7.47, with a volume of 45,795 shares trading hands.
Monroe Capital Trading Down 0.3%
The firm has a market capitalization of $163.83 million, a price-to-earnings ratio of 84.00 and a beta of 0.91. The business's 50 day moving average price is $6.64 and its 200-day moving average price is $7.01. The company has a debt-to-equity ratio of 1.16, a current ratio of 4.02 and a quick ratio of 4.02.
Monroe Capital (NASDAQ:MRCC - Get Free Report) last announced its quarterly earnings data on Monday, August 11th. The financial services provider reported $0.15 earnings per share for the quarter, missing analysts' consensus estimates of $0.21 by ($0.06). The business had revenue of $9.87 million during the quarter, compared to analysts' expectations of $12.38 million. Monroe Capital had a net margin of 3.74% and a return on equity of 10.70%. Equities analysts forecast that Monroe Capital Corporation will post 1.14 EPS for the current fiscal year.
Institutional Investors Weigh In On Monroe Capital
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Ascent Group LLC purchased a new stake in shares of Monroe Capital during the 1st quarter worth $80,000. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Monroe Capital during the 1st quarter worth approximately $84,000. Envestnet Asset Management Inc. raised its holdings in Monroe Capital by 13.3% during the fourth quarter. Envestnet Asset Management Inc. now owns 12,688 shares of the financial services provider's stock worth $108,000 after purchasing an additional 1,486 shares during the last quarter. Pandora Wealth Inc. purchased a new stake in shares of Monroe Capital in the 1st quarter worth about $113,000. Finally, Aspiriant LLC boosted its position in shares of Monroe Capital by 35.7% in the 2nd quarter. Aspiriant LLC now owns 19,000 shares of the financial services provider's stock worth $121,000 after buying an additional 5,000 shares in the last quarter.
About Monroe Capital
(
Get Free Report)
Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants.
Recommended Stories
Before you consider Monroe Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monroe Capital wasn't on the list.
While Monroe Capital currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.